Bio-Rad Laboratories, Inc. (BIO.B)

Bio-Rad Laboratories Stock Forecast

Stock Price Forecast

The 4 analysts that cover Bio-Rad Laboratories stock have a consensus rating of "Strong Buy" and an average price target of $358.5, which forecasts a 17.21% increase in the stock price over the next year. The lowest target is $310 and the highest is $409.

Price Target: $358.5 (+17.21%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$310	$358.5	$375	$409
Change	+1.36%	+17.21%	+22.61%	+33.73%

Analyst Ratings

The average analyst rating for Bio-Rad Laboratories stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jun '25	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25
Strong Buy	2	2	2	2	2	2
Buy	1	1	1	1	1	1
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Patrick Donnelly Citigroup	Citigroup	Strong Buy Maintains $350 → $375	Strong Buy	Maintains	$350 → $375	+22.61%	Oct 30, 2025
Brandon Couillard Wells Fargo	Wells Fargo	Hold Maintains $265 → $340	Hold	Maintains	$265 → $340	+11.17%	Oct 30, 2025
Conor McNamara RBC Capital	RBC Capital	Buy Maintains $387 → $409	Buy	Maintains	$387 → $409	+33.73%	Aug 1, 2025
Brandon Couillard Wells Fargo	Wells Fargo	Hold Maintains $245 → $265	Hold	Maintains	$245 → $265	-13.36%	Aug 1, 2025
Brandon Couillard Wells Fargo	Wells Fargo	Hold Maintains $260 → $245	Hold	Maintains	$260 → $245	-19.90%	Jun 9, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

2.62B

Increased by 1.89%

from 2.57B

Revenue Next Year

2.68B

Increased by 2.45%

from 2.62B

EPS This Year

10.15

from -65.36

EPS Next Year

10.44

Increased by 2.87%

from 10.15

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	2.55B	2.92B	2.80B	2.67B	2.57B	2.62B	2.68B
Revenue Growth	10.12%	14.81%	-4.12%	-4.68%	-3.92%	1.89%	2.45%
EPS	126.47	140.83	-121.79	-21.82	-65.36	10.15	10.44
EPS Growth	117.04%	11.35%	-	-	-	-	2.87%
Forward PE	-	-	-	-	-	30.15	29.31
No. Analysts	-	-	-	-	-	8	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	2.7B	2.8B
Avg	2.6B	2.7B
Low	2.5B	2.5B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	6.4%	8.0%
Avg	1.9%	2.4%
Low	-2.3%	-3.0%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	10.97	11.60
Avg	10.15	10.44
Low	9.12	8.08

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	14.3%
Avg	-	2.9%
Low	-	-20.4%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.